The broader trend suggests that other market forces (such as supply shocks, demand growth, and geopolitical risk) likely play ...

PAID CONTENT For at least the last 50 years, investors have successfully grown their assets by taking a 60/40 stocks-to-bonds ...

The S&P 500 closed out the shortened-trading week at a new record high, its third in the past four trading days.

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...

In describing U.S. equities' investment experience during the first half of the year, words like uncertain, tumultuous, and volatile come to mind; however, the asset class finished the period with a ...

Injective rises 5% on Thursday, adding to the double-digit gains from the previous day.

LONDON (Reuters) -What matters in U.S. and global markets today Global stocks are tiptoeing higher, while the U.S. dollar continues to struggle at three-year lows against a basket of currencies.

South Africa would need close to an economic miracle to reach the global average GDP per capita after years of poor ...

By learning the relevant features of clinical images along with the relationships between them, the neural network can outperform more traditional methods.

“The positive results from this confirmatory patient study represent an important step in the development of the Xolair® biosimilar candidate.

Metabolics Pharma Announces Positive Top-Line Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects ...

REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of ...